CUTANEOUS BLASTOMYCOSIS

This adverse event was reported 40 times

CUTANEOUS BLASTOMYCOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BELATACEPT 3 0.0006
1 MYCOPHENILIC ACID 6 0.0003
2 TACROLIMUS OINTMENT 0.1% 34 0.0003
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 34 0.0003
4 BASILIXIMAB 3 0.0003
5 TACROLIMUS 34 0.0002
6 MYCOPHENOLATE MOFETIL 26 0.0002
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 26 0.0002
8 MYCOPHENOLIC ACID 6 0.0002
9 ITRACONAZOLE 2 0.0002
See all drugs enriched for association with CUTANEOUS BLASTOMYCOSIS